Search filters

List of works by Dominick Angiolillo

"Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again?

scientific article published on March 2004

"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".

scientific article published in June 2006

807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment

scientific article (publication date: July 2004)

A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.

scientific article published in March 2018

A Safety Evaluation of Cangrelor in Patients Undergoing PCI.

scientific article published on 17 December 2015

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

scientific article published on 03 February 2016

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial ⬇️

scientific article published on January 20, 2011

A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease

scientific article

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.

scientific article published on 21 June 2008

A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reac

scientific article published on 18 April 2012

A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOV

scientific article published on 29 May 2012

A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery

scientific article published on 03 January 2008

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison

scientific article published on 01 December 2018

Acute coronary syndromes: applying practice guidelines and defining the unmet need in clinical practice

scientific article published on 08 January 2015

Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes.

scientific article published on 9 September 2010

Advances in antiplatelet therapy: agents in clinical development

scientific article published on February 2009

Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease ⬇️

scientific article published on July 19, 2012

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes: Results From a Randomized Trial

scientific article published on 21 July 2020

An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus

scientific article published on 14 July 2020

Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial

scientific article published in February 2007

Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes

scientific article published on 09 June 2003

Anticoagulation, the Unknown of the Antithrombotic Equation After Stenting of an Acute Coronary Syndrome

scientific article published on 01 February 2019

Antiplatelet Drug Therapy: Role of Pharmacodynamic and Genetic Testing ⬇️

scientific article published on May 1, 2011

Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions

scientific article

Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience

scientific article published on 01 October 2020

Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents ⬇️

scientific article published on August 1, 2013

Antiplatelet and Anticoagulation Therapy in Percutaneous Coronary Intervention

scientific article published on 01 January 2017

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

scientific article published on January 2009

Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials

scientific article published on 01 December 2020

Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.

scientific article published on March 2008

Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry

scientific article published on 12 July 2016

Antiplatelet therapy and platelet function testing.

scientific article published in March 2008

Antiplatelet therapy and platelet function testing. Introduction.

scientific article published in March 2008

Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?

scientific article published in June 2009

Antiplatelet therapy: thrombin receptor antagonists ⬇️

scientific article published on October 1, 2011

Antithrombotic Pharmacotherapy in the Elderly: General Issues and Clinical Conundrums

Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions

scientific article published on 15 September 2020

Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus

scientific article published on 30 November 2020

Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing Directions

scientific article published on 17 May 2017

Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease

scientific article

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update

scientific article published on 01 July 2018

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update ⬇️

journal article from 'Circulation' published in 2021

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update

scientific article published on November 2016

Antithrombotic therapy for acute coronary syndrome: Past, present and future

scientific article published on 8 June 2017

Antithrombotic therapy for patients with STEMI undergoing primary PCI.

scientific article published on 23 February 2017

Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease

scientific article

Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.

scientific article published on 04 October 2010

Antithrombotic therapy in the elderly

scientific article

Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).

scientific article published on February 2017

Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus

scientific article published on June 2009

Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation

scientific article published on 21 February 2008

Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus

scientific article published on 11 October 2016

Aspirin for primary prevention of cardiovascular disease

scientific article published on 26 August 2018

Aspirin for the primary prevention of cardiovascular disease: latest evidence

scientific article published on 16 August 2019

Aspirin treatment and outcomes in patients undergoing percutaneous coronary intervention: is there a role for pharmacodynamic testing?

scientific article published on 01 September 2014

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

scientific article published on 01 August 2018

Assessing the current role of platelet function testing.

scientific article published on March 2008

Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts

scientific article published on 05 October 2009

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

scientific article published on 18 January 2012

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program

scientific article published on 01 July 2012

Atopaxar: A Review of Its Mechanism of Action and Role in Patients With Coronary Artery Disease ⬇️

scientific article published on July 1, 2012

Atrial fibrillation, with ACS and PCI: walking a tightrope

scientific article published on 01 May 2019

Basic principles of platelet biology and clinical implications

scientific article published on 03 March 2010

Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and Anticoagulants

scientific article published on 22 July 2013

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

scientific article published on 26 September 2019

Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation

scientific article published on 20 February 2020

Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms

scientific article published on 25 October 2019

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

scientific article published on 20 April 2015

Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial

scientific article published on January 2012

COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial

scientific article published on 11 March 2020

COVID-19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management

scientific article published on 24 November 2020

CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction

scientific article published on 03 November 2018

Can resistance to aspirin be reversed after an additional dose?

scientific article published on 01 October 2011

Canakinumab for secondary prevention of atherosclerotic disease

scientific article

Cangrelor: a review on its mechanism of action and clinical development.

scientific article published on October 2009

Cangrelor: a review on pharmacology and clinical trial development

scientific article published on October 2013

Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study

scientific article published on 28 August 2006

Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study

scientific article published on 7 January 2014

Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.

scientific article published in March 2012

Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromes

scientific article published on 5 December 2017

Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention

scientific article published on 23 November 2019

Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention

scientific article published on March 2008

Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.

scientific article published on 8 February 2007

Clinical overview of promising nonthienopyridine antiplatelet agents

scientific article published on August 2008

Clinical profile of prasugrel, a novel thienopyridine

scientific article

Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery

scientific article published on 25 April 2013

Clopidogrel response variability: current status and future directions

scientific article published in July 2009

Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease

scientific article (publication date: March 2006)

Clopidogrel-statin interaction: myth or reality?

scientific article published on 10 July 2007

Clopidogrel–Drug Interactions ⬇️

scientific article published on March 15, 2011

Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome pro

scientific article published on June 2015

Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina

scientific article published on February 2003

Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents

scientific article published on 10 October 2020

Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor

scientific article published on 25 January 2017

Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in s

scientific article published on 01 October 2015

Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.

scientific article published in October 2008

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

scientific article published on September 2010

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

scientific article

Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.

scientific article

Contemporary issues on clopidogrel therapy: a critical appraisal

scientific article

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

scientific article (publication date: August 2006)

Contributors

Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies.

scientific article published in June 2004

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study

scientific article published on 21 March 2016

Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention

scientific article published on 01 February 2017

Current antiplatelet therapies: benefits and limitations

scientific article published on August 2008

Current concepts on coronary revascularization in diabetic patients ⬇️

scientific article published on 04 September 2011

De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis.

scientific article published in July 2019

De-escalation of oral P2Y<sub>12</sub> inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

scientific article published on 09 August 2019

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study ⬇️

scientific article published on 06 December 2012

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

scientific article published on 22 May 2019

Defining a Role for Prasugrel in Patients With Stable Coronary Artery Disease Undergoing Ad Hoc Percutaneous Coronary Intervention

scientific article published on 06 January 2016

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

scientific article published on 01 August 2019

Defining the link between chronic kidney disease, high platelet reactivity, and clinical outcomes in clopidogrel-treated patients undergoing percutaneous coronary intervention

scientific article published on 01 June 2015

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score

scientific article published on 01 March 2020

Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent

scientific article published on 05 October 2020

Diabetes and antiplatelet therapy in acute coronary syndrome.

scientific article published on February 2011

Diabetes and antiplatelet therapy: from bench to bedside.

scientific article published in October 2018

Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial

scientific article published on 24 March 2016

Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization

scientific article published on 08 April 2009

Diabetes mellitus: the scary killer haunting silently

scientific article published in April 2010

Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease ⬇️

scientific article published on November 16, 2011

Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial

scientific article published on 24 November 2020

Drug-Drug Interactions When Switching Between Intravenous and Oral P2Y12 Receptor Inhibitors: How Real Is It?

scientific article published on 01 January 2017

Drug-drug interactions between clopidogrel and novel cardiovascular drugs

scientific article published on 02 September 2015

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

scientific article

Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence

scientific article published on 28 June 2020

Dual antiplatelet therapy after coronary stenting

scientific article published on 16 June 2016

Dual antithrombotic therapy for atrial fibrillation and PCI

scientific article published on 03 September 2019

Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

scientific article published on 17 January 2020

Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?

scientific article published on 11 September 2020

Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial

scientific article published on 14 October 2020

Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography

scientific article published on 01 August 2018

Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemia

scientific article

Effect of platelet inhibition with cangrelor during PCI on ischemic events

scientific article

Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIP

scientific article published on 24 September 2013

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

scientific article published on 30 August 2019

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine

scientific article published on 31 July 2019

Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

scientific article published on 01 February 2016

Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.

scientific article published in February 2013

Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study

scientific article published on 3 December 2015

Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo")

scientific article published on 04 March 2011

Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus

scientific article published on 10 July 2012

Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome.

scientific article published on 24 August 2017

Elinogrel: pharmacological principles, preclinical and early phase clinical testing

scientific article published on July 2010

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways

scientific article published on 05 September 2013

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus

scientific article published on 5 January 2017

Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation

scientific article published on 01 April 2014

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial

scientific article published in May 2009

Evolution of coronary stent technology and implications for duration of dual antiplatelet therapy

scientific article

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting

scientific article published on 01 January 2019

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of

scientific article published on 09 July 2020

Extensive thrombus of distal anastomosis of saphenous vein graft

scientific article published on 01 April 2004

Fractional Flow Reserve-Based Coronary Artery Bypass Surgery: Current Evidence and Future Directions

scientific article published on 19 March 2020

Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment

scientific article published on 20 December 2007

Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study

scientific article published on 01 January 2008

Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

scientific article published on 12 January 2011

Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease

scientific article published on 23 September 2018

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease

scientific article (publication date: 5 September 2007)

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

scientific article published on 31 August 2008

Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group

scientific article

Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease

scientific article published on 09 June 2011

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

scientific article published in November 2004

High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.

scientific article published in May 2018

High-Dose Atorvastatin on the Pharmacodynamic Effects of Double-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Interventions

scientific article published on 01 February 2013

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients

scientific article published in January 2014

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

scientific article published on 23 January 2015

Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome

scientific article published on 01 August 2006

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

scientific article published in January 2005

Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization

scientific article published on December 2009

Imaging of atherosclerotic plaque

scientific article

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

article

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention

scientific article published on 29 March 2017

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Inves

scientific article published in September 2015

Impact of Gastric Acid–Suppressing Therapies on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Clopidogrel

scholarly article by John-Paul Pham et al published September 2011 in Journal of the American College of Cardiology

Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

scholarly article by Dominick J. Angiolillo et al published June 2011 in Journal of the American College of Cardiology

Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention

article

Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.

scientific article published on 13 November 2008

Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial

scientific article

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy

scientific article published on 26 May 2011

Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation

scientific article published on 25 July 2013

Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery

Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials

scientific article published on 30 May 2015

Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus

scientific article published on 27 October 2016

Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy

scientific article published in March 2010

Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease.

scientific article

Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.

scientific article published on July 2014

Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study

scientific article

Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease

scientific article

Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation

scientific article published on 21 December 2013

Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel

scientific article published in August 2011

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

scientific article (publication date: 16 October 2007)

Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy

scientific article published in February 2013

Impact of race and gender on antithrombotic therapy

article published in 2010

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

scientific article published on 10 January 2020

Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus

scientific article published on 01 July 2013

Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

scientific article

Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events).

scientific article

Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).

scientific article published on 9 April 2008

Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors

scientific article published on 04 August 2016

Impacto del tratamiento adyuvante con cilostazol comparado con dosis altas de mantenimiento de clopidogrel en pacientes con diabetes mellitus y respuesta subóptima

Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease

scientific article published on 01 September 2014

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibitio

scientific article published in April 2018

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study

scientific article published on September 2010

Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study ("Control de HIperglucemia y Actividad Plaqueta

scientific article published in February 2013

Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention

scientific article (publication date: 2006)

Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study

scientific article published in May 2012

Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial

scientific article published on 23 February 2016

Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease

scientific article published on 31 August 2006

Inhibiting PAR-1 in the prevention and treatment of atherothrombotic events ⬇️

scientific article published on October 28, 2010

Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy

scientific article published on October 2010

Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction

scientific article published on 01 March 2018

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

scientific article (publication date: 18 July 2006)

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patien

scientific article

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies

scientific article published on 30 October 2017

Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.

scientific article published on 19 August 2016

Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study.

scientific article published in August 2004

Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!

scientific article

Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty

scientific article published on 10 July 2015

Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation

scientific article published on 28 November 2005

Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis

scientific article

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use

scientific article published on 01 January 2019

Investigating the mechanisms of hyporesponse to antiplatelet approaches

scientific article published on March 2008

In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Ticagrelor-Treated Patients

scientific article published on 01 July 2017

Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study

scientific article (publication date: June 2004)

Isolated distal coronary dissection in Marfan syndrome

scientific article published on 01 April 2004

LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study

scientific article published on 21 July 2005

La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicas

Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

scientific article (publication date: December 2006)

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

scientific article

Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?

scientific article (publication date: May 2004)

Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review

scientific article published on 08 December 2020

Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies

scientific article published on 29 January 2020

Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial

scientific article (publication date: August 2007)

Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

scientific article

Long-term outcome of patients with proximal left anterior descending coronary artery in-stent restenosis treated with a second percutaneous procedure.

scientific article published in April 2005

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

scientific article published on 24 September 2008

Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease

scientific article

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review

scientific article published on 01 July 2019

Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCI.

scientific article published on 23 July 2015

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions

scientific article published on February 2014

Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery

scientific article published on December 2013

Mechanism of action and clinical development of platelet thrombin receptor antagonists.

scientific article published on August 2010

Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist

scientific article published on February 2010

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention

scientific article (publication date: 15 October 2007)

Methodologic considerations on four cardiovascular interventions trials with contradictory results

scientific article published on 12 June 2020

New directions in antiplatelet therapy

scientific article

New oral anticoagulants and dual antiplatelet therapy: Focus on apixaban

scientific article

Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management

scientific article published on 05 August 2020

Novel Antiplatelet Agents: The Current State and What Is Coming Down the Pike

scientific article published on 12 August 2015

Novel antiplatelet agents in acute coronary syndrome

scientific article published on 07 October 2014

Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluation

scientific article published on 18 June 2014

Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations

scientific article published on 01 April 2011

Oral Anticoagulation After TAVR in Patients With Atrial Fibrillation: The Certainty of Uncertainty

scientific article published on 12 June 2019

Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.

scientific article published on October 2010

Oral trans-mucosal administration of ticagrelor: is this really the future?

scientific article published on 23 March 2017

Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis

scientific article published on 12 October 2020

P2Y-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes

scientific article published on 01 October 2018

Percutaneous Interventional Repair of an Intraoperative Right Coronary Artery Tear

scientific article

Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma

scientific article

Percutaneous coronary interventions in ST-segment-elevation myocardial infarction: shifting paradigms and future perspectives

scientific article published in December 2013

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

scientific article published on May 2014

Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery

scientific article published on 02 October 2014

Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery

scientific article

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study

scientific article published on 24 August 2016

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study

scientific article published on 21 March 2016

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study.

scientific article

Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation

scientific article

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study

scientific article published on 20 April 2020

Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study

scientific article published on 01 September 2019

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Interventi

scientific article published on 12 October 2020

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

scientific article published on 12 May 2009

Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation ⬇️

scientific article published on January 1, 2014

Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers ⬇️

scientific article published on October 1, 2012

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.

scientific article published on 17 April 2012

Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status

scientific article published on 01 May 2014

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials ⬇️

scientific article published on 01 July 2012

Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients

scientific article published on 13 March 2014

Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study

scientific article published on 21 September 2010

Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease

scientific article published on 08 March 2011

Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study

scientific article published on 01 May 2012

Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.

scientific article

Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study

scientific article published on 26 April 2011

Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2).

scientific article published on 12 December 2013

Pharmacodynamics During Transition Between Platelet P2Y12 Inhibiting Therapies

scientific article published on 11 July 2019

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes

scientific article published on 14 November 2019

Pharmacogenetics in cardiovascular antithrombotic therapy

scientific article published on 01 September 2009

Pharmacogenomic Testing to Select Antiplatelet Therapy

scientific article published on 01 May 2018

Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patie

scientific article published on 22 May 2012

Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients

scientific article published on 18 December 2018

Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study

scientific article published on 01 November 2019

Pharmacology of emerging novel platelet inhibitors

scientific article published on August 2008

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

scientific article (publication date: 2004)

Platelet Function Profiles in Patients with Diabetes Mellitus ⬇️

scientific article published on February 13, 2013

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

scientific article published on 01 April 2019

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

scientific article

Platelet P2Y₁₂ receptor inhibition: an update on clinical drug development

scientific article published on January 2010

Platelet abnormalities in diabetes mellitus

scientific article published on 04 October 2010

Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions

scientific article published on January 2010

Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?

scientific article (publication date: April 2004)

Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease

scientific article published on March 2012

Platelet function and genetic testing.

scientific article published on October 2013

Platelet function assessment to predict outcomes after coronary interventions: hype or hope?

scientific article published on 17 October 2006

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

scientific article (publication date: August 2005)

Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity

Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure

scientific article published on 01 October 2007

Platelet function testing and risk of bleeding complications

scientific article published on 29 March 2010

Platelet function testing in contemporary clinical and interventional practice

scientific article published in May 2014

Platelet inhibition with cangrelor in patients undergoing PCI.

scientific article published in December 2009

Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitus.

scientific article published on 15 August 2015

Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction

scientific article published in August 2008

Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial

scientific article published on 29 August 2011

Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis

scientific article

Platelet thrombin receptor antagonism and atherothrombosis

scientific article

Platelet thrombin receptor antagonism with vorapaxar: pharmacology and clinical trial development

scientific article published on 25 September 2015

Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.

scientific article published on 12 June 2017

Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory

scientific article published on 5 June 2015

Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?

scientific article published on 03 January 2020

Prasugrel

scientific article published on 09 August 2012

Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

scientific article

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing

scientific article published on 25 March 2020

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

scientific article published on 3 December 2007

Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development ⬇️

scientific article published on December 13, 2010

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

scientific article published on April 2009

Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development

Pre-Treatment With Oral P2Y12 Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga Continues

scientific article published on 01 March 2019

Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction—1-year follow-up results of the COMPARE CRUSH trial

scientific article published in 2022

Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy

scientific article published on 26 July 2015

Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?

scientific article published on 01 January 2017

Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines

scientific article published on March 2015

Prevalence, Predictors, and Long-Term Prognosis of Premature Discontinuation of Oral Antiplatelet Therapy After Drug Eluting Stent Implantation

scientific article published on 01 January 2011

Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention

scientific article published on 01 January 2006

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation

Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: a comparative study versus standard digital angiography

scientific article

Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve

scientific article published on 23 July 2007

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study

scientific article published on 29 January 2007

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial

scientific article

Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (IS

scientific article published on 27 December 2013

Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial

scientific article published on 18 April 2011

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study

article

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease ⬇️

scientific article published on June 19, 2012

Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.

scientific article published on 30 March 2016

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

scientific article published on 31 December 2012

Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial

scientific article published on 17 October 2012

Refining the Role of Antiplatelet Therapy in Medically Managed Patients With Acute Coronary Syndrome ⬇️

scientific article published on November 17, 2012

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.

scientific article published in June 2016

Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss

scientific article published in February 2007

Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?

scientific article published on 01 June 2017

Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.

scientific article published in January 2017

Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent

scientific article published on 01 September 2020

Reply: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment: An Area of Unmet Need

scientific article published on 01 September 2019

Reply: Therapeutic Window of P2Y12 Inhibition: Should the Current Limits Be Modified?

scientific article published on 01 December 2019

Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention

scientific article published on 01 April 2015

Response by Angiolillo et al to Letter Regarding Article, "International Expert Consensus Document on Switching Platelet P2Y12 Receptor Inhibiting Therapies"

scientific article published on 01 May 2018

Response to Letter Regarding Article, “Antithrombotic Therapy in Patients With Chronic Kidney Disease”

Response to Letter Regarding Article, “Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tail

Response to Letter Regarding Article, “Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease”

Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patients

scientific article published on 8 March 2016

Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside

scientific article published on January 2017

Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention

scientific article published on 10 July 2017

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations

scientific article published on 12 July 2019

Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists

scientific article published in July 2015

Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

scientific article published on 01 August 2020

Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions

scientific article published on 12 November 2020

Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery

scientific article published in April 2013

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

scientific article published on 4 February 2016

Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial

scientific article published on 18 April 2011

Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development

scientific article published on 12 May 2020

Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies

scientific article published on 30 March 2020

Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case series

scientific article published on 27 August 2016

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

scientific article published on July 1, 2013

Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.

scientific article published on August 2005

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

scientific article published on March 2011

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)

scientific article published on 09 July 2018

Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes

scientific article published on 27 June 2019

Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice

scientific article published on 01 October 2013

Switching P2Y12 Receptor Inhibiting Therapies

scientific article published on 01 January 2017

Switching P2Y12-receptor inhibitors in patients with coronary artery disease

scientific article published on 18 August 2015

Switching from prasugrel to clopidogrel: navigating in unknown waters

scientific article published on 01 February 2013

Systematic Assessment of Online Health Information for Coronary Revascularization

scientific article published on 01 July 2021

Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index

scientific article published on 11 December 2019

Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes.

scientific article published on 4 April 2018

TCT-46 Pre-Hospital Crushed Versus Integral Prasugrel Loading Dose in Patients Presenting With Anterior ST-Segment Elevation Myocardial Infarction—A COMPARE CRUSH Subanalysis

scientific article published in 2022

Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus

scientific article published in June 2011

Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the Unknown

scientific article published on 01 January 2019

Tailoring P2Y12 Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

scientific article published on 05 September 2019

Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design

scientific article published on 17 June 2008

Targeting Platelet Nitric Oxide Resistance With Ramipril

Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damage

scientific article published on 10 March 2013

The Conundrum Surrounding Racial Differences on Ischaemic and Bleeding Risk with Dual Anti-Platelet Therapy

scientific article published on 31 December 2018

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

scientific article published on 10 November 2020

The GRAVITAS study

scientific article published on 01 January 2012

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel ⬇️

scientific article published on April 16, 2013

The Quest for the Optimal Periprocedural Antithrombotic Treatment Strategy in ACS Patients Undergoing PCI

scientific article published on 01 March 2018

The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.

scientific article published on 17 November 2016

The impact of previously occluded noninfarct vessels in patients with acute myocardial infarction.

scientific article published on 29 December 2006

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study

scientific article published on 21 May 2014

The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention

scientific article published on March 2008

The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts

scientific article published in November 2017

The role of oral anticoagulant therapy in patients with acute coronary syndrome

scientific article published on 13 October 2017

Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis

scientific article published on 24 September 2019

Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot Study

scientific article published on July 2015

Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis

scientific article published on 13 March 2020

Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy

scientific article published on 01 February 2020

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

scientific article published on 27 June 2011

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease

scientific article

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

scientific article published on 16 October 2020

Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial

scientific article published on 14 May 2020

Ticagrelor or Clopidogrel in Elderly Patients with Myocardial Infarction: When the Choice Makes the Difference

scientific article published on 01 September 2020

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

scientific article published on 01 November 2020

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus

scientific article published on 01 October 2020

Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes

scientific article published on 01 November 2020

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

scientific article published on 01 September 2019

Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

scientific article published on 29 October 2020

Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial

scientific article published on 02 August 2018

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article

Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study

scientific article

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

scientific article published on 26 September 2019

Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention

scientific article published on 19 March 2020

Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome

scientific article published on 26 August 2020

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel

scientific article published on 01 September 2020

Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath Water

scientific article published on 11 May 2017

Tug of War Between Dual and Triple Antithrombotic Therapy in Atrial Fibrillation/PCI Patients With CKD

scientific article published on 01 August 2019

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar

scientific article

Update on oral antithrombotic therapy for secondary prevention following non-ST segment elevation myocardial infarction

scientific article published on 11 August 2015

Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice ⬇️

scientific article published on July 1, 2013

Update on the clinical development of cangrelor.

scientific article published on August 2010

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

scientific article published on 12 June 2019

Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery

scientific article published on April 2017

Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention

scientific article published on 03 September 2009

Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients

scientific article published on 01 June 2020

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

scientific article (publication date: 10 April 2007)

Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene

scientific article (publication date: 15 October 2005)

Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial

scientific article published in July 2014

Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

scientific article published on 15 May 2006

Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data

scientific article

Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial

scientific article

When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by Ticagrelor

scientific article published on 11 December 2020

[Antiplatelet and anticoagulant therapy in elderly patients]

scientific article published on 01 March 2011

[Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation]

scientific article published on 01 July 2012

[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial]

scientific article published on 01 October 2006

[Inflammation in acute coronary syndromes: mechanisms and clinical implications]

scientific article published on 01 May 2004

[Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines]

scientific article published on 01 May 2015

[Predictors of mortality following rescue percutaneous intervention]

scientific article published on 01 December 2004

Paulina is supported by:

About Paulina

Help